LobbyingSound Pharmaceuticals lobbying by quarter
Sound Pharmaceuticals's latest lobbying report covers Q2 2026, at $60K. Its first report covers Q1 2026; the issues it reports most are Budget/Appropriations and Defense.
Sound Pharmaceuticals
- Latest quarter
- $60K
- Q2 2026 · 1 reports
- Last 12 months
- $70K
- Last 2 quarters
- vs last quarter
- +500.0%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $10K | 1 |
| Q2 2026 | $60K | 1 |
Policy issues the reports name
- Budget and appropriations2 reports
- Defense2 reports
- Medical research and clinical labs2 reports
- Veterans2 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| Holland & Knight | $70K | 2 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/15for Q2 | Holland & Knight | $60K |
| 04/20for Q1 | Holland & Knight | $10K |
| 04/20for Q1 | Holland & Knight | Under $5,000 |